Last reviewed · How we verify
Chronic thromboembolic pulmonary hypertension
Approved treatments
- Adempas · University of Colorado, Denver
- Adempas · Bayer
Adempas works by stimulating the soluble guanylate cyclase enzyme to increase levels of cyclic guanosine monophosphate (cGMP), a signaling molecule that helps to relax blood vessels.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic thromboembolic pulmonary hypertension patent landscape — cliff calendar, originator estates, attackable patents
- Chronic thromboembolic pulmonary hypertension treatment landscape brief
- Chronic thromboembolic pulmonary hypertension treatment updates RSS
Frequently asked questions about Chronic thromboembolic pulmonary hypertension
What drugs treat Chronic thromboembolic pulmonary hypertension?
Tracked treatments include Adempas.
What is the treatment for Chronic thromboembolic pulmonary hypertension?
Standard treatment for Chronic thromboembolic pulmonary hypertension includes Adempas. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic thromboembolic pulmonary hypertension patent cliff · Chronic thromboembolic pulmonary hypertension CI report
- Treatment: Adempas · University of Colorado, Denver
- Treatment: Adempas · Bayer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing